GLP-1 Agonists Combined With SGLT2 Inhibitors Reduce Weight in Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Glucagon-like peptide-1 agonists combined with sodium-glucose cotransporter-2 inhibitors reduce weight in type 1 diabetes
Obesity 2023 Mar 01;31(3)716-723, E Al-Ozairi, M Irshad, E Taghadom, L Sojan, J Al Kandari, D Alroudhan, CW le RouxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.